Wide Ranks

ACTU

Actuate Therapeutics, Inc.

8.68

Top Statistics
Market Cap 169 M Forward PE 0.0000 Revenue Growth 0.00 %
Current Ratio 0.03 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins 0.00 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA Enterprise / Revenue Price To Sales Trailing12 Months
Profitability
Profit Margins 0.00 % Operating Margins
Balance Sheet
Total Cash 351709 Total Cash Per Share 0.0180 Total Debt 6 M
Total Debt To Equity Current Ratio 0.03 Book Value Per Share -58.92
All Measures
Short Ratio 49.00 % Message Board Id finmb_313171219 Shares Short Prior Month 13174
City Fort Worth Uuid a36078c9-3fe4-3046-b959-8723608de23f Previous Close 9.00
First Trade Date Epoch Utc 1 B Book Value -58.92 Total Debt 6 M
Volume 53851 Fifty Two Week Low 5.51 Total Cash Per Share 0.0180
Shares Short Previous Month Date 1 B Max Age 86400 Sand P52 Week Change 0.3133
Net Income To Common -28818356 Ask 8.88 Implied Shares Outstanding 19 M
Trailing Peg Ratio None Last Fiscal Year End 1 B Average Daily Volume10 Day 56490
Average Volume10days 56490 Total Cash 351709 Next Fiscal Year End 1 B
Held Percent Insiders 0.1869 Trailing PE 0.0000 Date Short Interest 1 B
Most Recent Quarter 1 B Regular Market Previous Close 9.00 Target Low Price 0.0000
Gmt Off Set Milliseconds -18000000 Fifty Day Average 7.96 Open 9.18
Dividend Yield 0.00 % State TX Time Zone Short Name EST
Trailing Eps -1.46 Day Low 8.60 Address1 1751 River Run
Shares Outstanding 19 M Price Hint 2 Target High Price 0.0000
Website https://actuatetherapeutics.com 52 Week Change 0.0081 Average Volume 46404
Recommendation Key none Forward Eps 0.0000 Compensation As Of Epoch Date 1 B
Quick Ratio 1.80 % Is_sp_500 False Regular Market Day High 9.18
Profit Margins 0.00 % Fifty Two Week High 10.16 Day High 9.18
Shares Short 20250 Regular Market Open 9.18 Industry Key biotechnology
Bid 8.54 Earnings Growth 0.00 % Revenue Growth 0.00 %
Shares Percent Shares Out 0.0010 Operating Cashflow -19071316 Currency USD
Time Zone Full Name America/New_York Market Cap 169 M Is_nasdaq_100 False
Zip 76107 Quote Type EQUITY Industry Biotechnology
Long Name Actuate Therapeutics, Inc. Common stock Regular Market Day Low 8.60 Held Percent Institutions 0.5305
Current Price 8.68 Address2 Suite 400 Financial Currency USD
Current Ratio 0.03 Industry Disp Biotechnology Country United States
Float Shares 6 M Two Hundred Day Average 8.07 Enterprise Value 268 M
Forward PE 0.0000 Regular Market Volume 53851 Exchange NGM
Go to Yahoo Finance Go to Seeking Alpha 
Actuate Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of cancers.

The company's lead product candidate is Elraglusib Injection, a novel glycogen synthase kinase-3 inhibitor to treat metastatic pancreatic ductal adenocarcinoma.

It also develops Elraglusib for the treatment of Ewing sarcoma, metastatic melanoma, and colorectal cancer.

The company was formerly known as Apotheca Therapeutics, Inc. and changed its name to Actuate Therapeutics, Inc. in October 2015.

The company was incorporated in 2015 and is based in Fort Worth, Texas.